A transmembrane aspartyl protease, termed β-site APP cleaving enzyme 1 (BACE1), initiates Alzheimer's disease (AD) β-amyloid (Aβ) production by sequential proteolysis of amyloid precursor protein (APP) [1-5]. Here, APP is linked to Alzheimer disease.